Related references
Note: Only part of the references are listed.A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables
C. A. Siegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Mean Platelet Volume in Crohn's Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study
Aleksandra Sobolewska et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review
Travis B Murdoch et al.
Canadian Journal of Gastroenterology and Hepatology (2016)
Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis
R. S. Choung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial
William J. Sandborn et al.
GASTROENTEROLOGY (2016)
Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway
Manreet Kaur et al.
INFLAMMATORY BOWEL DISEASES (2016)
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis
Klaus Theede et al.
INFLAMMATORY BOWEL DISEASES (2016)
Genetics and phenotypes in inflammatory bowel disease
Joana Torres et al.
LANCET (2016)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Isabelle Cleynen et al.
LANCET (2016)
A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
Stacy B. Menees et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study
Ryota Iwasa et al.
BMC GASTROENTEROLOGY (2015)
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
Maria Theresa Arias et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
Emily K. Wright et al.
GASTROENTEROLOGY (2015)
Biomarkers of Inflammation in Inflammatory Bowel Disease
Bruce E. Sands
GASTROENTEROLOGY (2015)
Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases
Marla Dubinsky et al.
GASTROENTEROLOGY (2015)
Blood-based Biomarkers Used to Predict Disease Activity in Crohn's Disease and Ulcerative Colitis
Robert Burakoff et al.
INFLAMMATORY BOWEL DISEASES (2015)
Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study
Peter Townsend et al.
INFLAMMATORY BOWEL DISEASES (2015)
Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases
Edmond Y. Huang et al.
INFLAMMATORY BOWEL DISEASES (2015)
Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing: A Post hoc Analysis from SONIC
Guillaume Bouguen et al.
INFLAMMATORY BOWEL DISEASES (2015)
Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohn's Disease
Gilles Boschetti et al.
INFLAMMATORY BOWEL DISEASES (2015)
Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
Luz Maria Medrano et al.
MEDIATORS OF INFLAMMATION (2015)
Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study)
Inger Camilla Solberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
Niels Vande Casteele et al.
GUT (2015)
Neutrophil gelatinase-associated lipocalin levels associated with cardiovascular disease in chronic kidney disease patients
Fumihiko Furuya et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review
S. Pathak et al.
COLORECTAL DISEASE (2014)
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year
Luisa Guidi et al.
DIGESTIVE AND LIVER DISEASE (2014)
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
Freddy Cornillie et al.
GUT (2014)
Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data
Guo-Bo Chen et al.
HUMAN MOLECULAR GENETICS (2014)
Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease
Uri Kopylov et al.
INFLAMMATORY BOWEL DISEASES (2014)
Molecular Patterns in Human Ulcerative Colitis and Correlation with Response to Infliximab
Brendan Halloran et al.
INFLAMMATORY BOWEL DISEASES (2014)
Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity
Jin-Feng Lin et al.
INFLAMMATORY BOWEL DISEASES (2014)
C-reactive protein and lung diseases
Marianna Agassandian et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis
Michitaka Kohashi et al.
JOURNAL OF CROHNS & COLITIS (2014)
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2014)
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease
Toshifumi Hibi et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease
Chien-Chih Tung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Adeno-associated Virus-mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis
Priyanka Patel et al.
MOLECULAR THERAPY (2014)
C-Reactive Protein as a Prognostic Factor for Human Osteosarcoma: A Meta-Analysis and Literature Review
Jian-Hua Yi et al.
PLOS ONE (2014)
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease
M. Iborra et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Metabolomics: is it useful for inflammatory bowel diseases?
Martin Storr et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients
Scott Plevy et al.
INFLAMMATORY BOWEL DISEASES (2013)
Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
Martin Bortlik et al.
JOURNAL OF CROHNS & COLITIS (2013)
Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease
Na-Young Han et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
MicroRNA expression patterns in indeterminate inflammatory bowel disease
Jingmei Lin et al.
MODERN PATHOLOGY (2013)
Gene Expression Analysis of Peripheral Cells for Subclassification of Pediatric Inflammatory Bowel Disease in Remission
Pieter P. E. van Lierop et al.
PLOS ONE (2013)
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis
Nina Aagaard Poulsen et al.
BMC GASTROENTEROLOGY (2012)
Outcome Predictors for Thiopurine Maintenance Therapy in Patients with Crohn's Disease
Jae Jun Park et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
Pauliina Molander et al.
INFLAMMATORY BOWEL DISEASES (2012)
miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes
Joel R. Pekow et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Circulating MicroRNA in inflammatory bowel disease
Archanioti Paraskevi et al.
JOURNAL OF CROHNS & COLITIS (2012)
Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease
Na-Young Han et al.
JOURNAL OF DIGESTIVE DISEASES (2012)
Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity
K. A. Oikonomou et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by 1H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals
Rudolf Schicho et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Comparative proteomics analysis of serum proteins in ulcerative colitis patients
Nan Li et al.
MOLECULAR BIOLOGY REPORTS (2012)
C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
Stephen Kaptoge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis
Radha Duttagupta et al.
PLOS ONE (2012)
Biofluid metabonomics using 1H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology
Neeral R. Patel et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment
Ingrid Arijs et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis
Gary Toedter et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
James D. Lewis
GASTROENTEROLOGY (2011)
Real-time Tool to Display the Predicted Disease Course and Treatment Response for Children with Crohn's Disease
Corey A. Siegel et al.
INFLAMMATORY BOWEL DISEASES (2011)
Blood-based Biomarkers Can Differentiate Ulcerative Colitis from Crohn's Disease and Noninflammatory Diarrhea
Robert Burakoff et al.
INFLAMMATORY BOWEL DISEASES (2011)
Combination of Genetic and Quantitative Serological Immune Markers are Associated with Complicated Crohn's Disease Behavior
Gary R. Lichtenstein et al.
INFLAMMATORY BOWEL DISEASES (2011)
Peripheral Blood MicroRNAs Distinguish Active Ulcerative Colitis and Crohn's Disease
Feng Wu et al.
INFLAMMATORY BOWEL DISEASES (2011)
Antimicrobial Peptide Response to Blood Translocation of Bacterial DNA in Crohn's Disease Is Affected by NOD2/CARD15 Genotype
Ana Gutierrez et al.
INFLAMMATORY BOWEL DISEASES (2011)
Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease
Adam M. Zahm et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Elevated Serum Neutrophil Gelatinase-Associated Lipocalin Is an Early Predictor of Severity and Outcome in Acute Pancreatitis
Subhankar Chakraborty et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
Waqqas Afif et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets
Bertalan Mesko et al.
BMC MEDICAL GENOMICS (2010)
Neutrophil Gelatinase-Associated Lipocalin A Biomarker in COPD
Tomas M. Eagan et al.
CHEST (2010)
Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study
Lamia Kallel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
S100 Calgranulins in inflammatory arthritis
Chandima Perera et al.
IMMUNOLOGY AND CELL BIOLOGY (2010)
Genome Wide Association (GWA) Predictors of Anti-TNFα Therapeutic Responsiveness in Pediatric Inflammatory Bowel Disease
Marla C. Dubinsky et al.
INFLAMMATORY BOWEL DISEASES (2010)
Identification of MicroRNAs Associated with Ileal and Colonic Crohn's Disease
Feng Wu et al.
INFLAMMATORY BOWEL DISEASES (2010)
Predictive Value of Epithelial Gene Expression Profiles for Response to Infliximab in Crohn's Disease
Ingrid Arijs et al.
INFLAMMATORY BOWEL DISEASES (2010)
MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell Differentiation
Hang Thi Thu Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential Regulation of Peripheral Leukocyte Genes in Patients With Active Crohn's Disease and Crohn's Disease in Remission
Robert Burakoff et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis
Tomohisa Takagi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Metabonomics in Ulcerative Colitis: Diagnostics, Biomarker Identification, And Insight into the Pathophysiology
Jacob T. Bjerrum et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Patrick F. van Rheenen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
I. Arijs et al.
GUT (2009)
Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2009)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Lipocalin2 Expressions Correlate Significantly With Tumor Differentiation in Epithelial Ovarian Cancer
HanByoul Cho et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Proteomics for prediction and characterization of response to infliximab in Crohn's disease:: A pilot study
Marie-Alice Meuwis et al.
CLINICAL BIOCHEMISTRY (2008)
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Marla C. Dubinsky et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Inflammation, adenoma and cancer: Objective classification of colon biopsy specimens with gene expression signature
Orsolya Galamb et al.
DISEASE MARKERS (2008)
MicroRNAs Are Differentially Expressed in Ulcerative Colitis and Alter Expression of Macrophage Inflammatory Peptide-2α
Feng Wu et al.
GASTROENTEROLOGY (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease
D. Foell et al.
JOURNAL OF PATHOLOGY (2008)
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease
Jolanta Malyszko et al.
RENAL FAILURE (2008)
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
T. Kaiser et al.
GUT (2007)
Assessment of endoscopic activity lndex and biological lnflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
Marie-Arrhelle Denis et al.
INFLAMMATORY BOWEL DISEASES (2007)
Assessment of reliability and validity of IBD phenotyping within the national institutes of diabetes and digestive and kidney diseases (NIDDK) IBD genetics consortium (IBDGC)
Themistocles Dassopoulos et al.
INFLAMMATORY BOWEL DISEASES (2007)
Genome-vide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis
Feng Wu et al.
INFLAMMATORY BOWEL DISEASES (2007)
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease
Marco Scarpa et al.
DISEASES OF THE COLON & RECTUM (2007)
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease
Julian R. Marchesi et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease
George E. Reese et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Fecal S100A12: A novel noninvasive marker in children with Crohn's disease
Naomi S. H. de Jong et al.
INFLAMMATORY BOWEL DISEASES (2006)
The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool
CC Liew et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Clinically active Crohn's disease in the presence of a low C-reactive protein
THJ Florin et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells
ME Burczynski et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression
MC Dubinsky et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells
JC Rockett et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease
F Ye et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Fecal lactoferrin: A new parameter to monitor infliximab therapy
S Buderus et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
JA Tibble et al.
GASTROENTEROLOGY (2002)
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis
M Carlson et al.
GUT (2002)
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
EA Vasiliauskas et al.
GUT (2000)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998
C Gasche et al.
INFLAMMATORY BOWEL DISEASES (2000)
Share Paper
